http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012001093-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea740e4295be3b4b09ba3bb380468e98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba903902f9f8c05c80c0c80ad6492923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ec7b412bb241c0b8c9025a1b96ee4fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
filingDate 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa1c576f03902bcca7c360bb426270c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440c5cbe06f16850ecbea604e21f7ffc
publicationDate 2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012001093-A3
titleOfInvention Liquid formulations of rupatadine fumarate
abstract The present invention provides cyclodextrin-free aqueous liquid formulations of rupatadine fumarate, useful for the treatment of allergic rhinitis and urticaria. Said formulations comprise rupatadine fumarate, one or more cosolvents and one or more pH regulating agents wherein the composition has a pH between 4 and 6.5.
priorityDate 2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006131737-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0577957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2087818-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6449107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450143291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226541279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226540955

Total number of triples: 39.